A, R., A, L., A, C., FA, C., MB, B., B, B., . . . C, S. (2025). Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: Current evidence and future directions. Journal of translational medicine, 24(1), 15. https://doi.org/10.1186/s12967-025-07471-6
Chicago Style (17th ed.) CitationA, Russotto, Longobardi A, Ciullini A, Cazzaniga FA, Bacınoğlu MB, Borroni B, Ghidoni R, Moda F, and Saraceno C. "Biomarkers for Lewy Body Diseases and Other Alpha-synucleinopathies in Biofluids: Current Evidence and Future Directions." Journal of Translational Medicine 24, no. 1 (2025): 15. https://doi.org/10.1186/s12967-025-07471-6.
MLA (9th ed.) CitationA, Russotto, et al. "Biomarkers for Lewy Body Diseases and Other Alpha-synucleinopathies in Biofluids: Current Evidence and Future Directions." Journal of Translational Medicine, vol. 24, no. 1, 2025, p. 15, https://doi.org/10.1186/s12967-025-07471-6.